| [ Summary ] |
There are big differences in the therapy of end stage renal diseases (ESRD) between in U.S.A., Canada and Japan. The most remarkable differences between them were percentages of renal transplant patients in all ESRD patients. Secondly, percentages of CAPD patients were also different, 6% in Japan, 15% in U.S.A. and 35% in Canada. Mortality rate of hemodialysis patients in U.S.A. and Canada were remarkably higher than that in Japan because of severity of patient states and shortage of dialysis doses. In U.S.A. 70.9 % of hemodialysis patients were treated with reused dialyzers, and in general one dialyzer was reused more than 20 times. In such situation, nearly 90% of hemodialysis patients were received erythropoietin (EPO) administrations, and more than 10,000 IU/week used for those patients in U.S.A. |